Mode
Text Size
Log in / Sign up
N/A N=152 Randomized Triple-blind Treatment

Improving ADHD Teen Driving

Attention Deficit Disorder · Attention Deficit Disorder With Hyperactivity

Enrolled (actual)
152
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcome: Primary: Number of Extended Glances Away From Roadway During Driving Simulation — 16.5; 28.0 number of long glances — p=<.0001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
FOCAL+ (Behavioral); Rules of The road (Other)
Age
Pediatric, Adult · 16+ yrs
Sex
All
Sponsor
Children's Hospital Medical Center, Cincinnati
Primary completion
Dec 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Extended Glances Away From Roadway During Driving Simulation
15.7; 27.0 <.0001 sig
PRIMARY
Standard Deviation of Lateral Position During Driving Simulation
.98; 1.20 <.0001 sig
PRIMARY
Number of Extended Glances Away From Roadway During Driving Simulation
15.7; 27.0 <.0001 sig
PRIMARY
Standard Deviation of Lateral Position During Driving Simulation
.98; 1.20 <.0001 sig
SECONDARY
Number of Incidents, Crashes, and Near-crashes Recorded With DriveCam
110; 159
SECONDARY
Number of DriveCam Events That Are Preceded by a 2 Second or Greater Glance Away From the Roadway
588; 674

Summary

Teens with Attention-Deficit/Hyperactivity Disorder (ADHD) have high rates of negative driving outcomes, including motor vehicle crashes, which may be caused by visual inattention (i.e., looking away from the roadway to perform secondary tasks). A driving intervention that trains teens to reduce instances of looking away from the roadway will be tested in teens with ADHD.

Eligibility Criteria

Inclusion Criteria

  • Aged 16-19.
  • Must meet DSM-5 ADHD criteria for ADHD-Predominantly Inattentive Presentation or ADHD-Combined Presentation based on the K-SADS interview.
  • Possess a valid driver's license and regularly spend at least 3 hours per week engaged in unsupervised driving.
  • IQ ≥80 as measured by the Wechsler Abbreviated Intelligence Scale-II (WASI-II)
  • Parent willing to participate..

Exclusion Criteria

  • On ADHD medication that cannot be washed out on assessment days.
  • Drug or alcohol dependence according to K-SADS interview.
  • On psychotropic or neuroleptic medications.
  • Require eye glasses (contacts acceptable) for driving (corrective vision restriction on driver's license).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02848092). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search